Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of corticotrophin-releasing hormone on esophageal sensitivity in healthy volunteers
2014-000602-36Phase 4Completed
- Sponsor
- KU Leuven
- Start
- Feb 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial comparing CRH Ferring with Placebo (2 arms). Primary endpoint: Altered esophageal sensitivity after administration of CRH vs placebo. Started Feb 2014; status: completed.
02
Drugs
corticorelin
Beyond the preview
Go deeper on 2014-000602-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000602-36.